BRISTOL-MYERS BUFFERIN STUDIES SUPPORT OTC CLAIM OF REDUCED STOMACH DISTRESS WHEN USED SHORT-TERM, FDA SAYS; CHRONIC USE CLAIM NEEDS FURTHER DATA

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".